Mango Sciences
VerifiedUSD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | - | (6 %) |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | $0.0 | round |
N/A | $0.0 | round | |
investor | $0.0 | round | |
investor | $0.0 | round | |
investor | $0.0 | round | |
$4.2m | Series A | ||
Total Funding | 000k |
Related Content
Recent News about Mango Sciences
EditMango Sciences is a forward-thinking startup dedicated to transforming the healthcare industry by focusing on patient welfare. The company operates at the intersection of healthcare and technology, providing innovative solutions that enhance patient care and accessibility to advanced treatments. Mango Sciences serves a diverse range of clients, including healthcare providers, life science companies, and financial institutions.
For healthcare providers, Mango Sciences offers data-driven insights and tools that help deliver consistent, high-quality care. This includes improving access to cutting-edge treatments and ensuring that patient care is both individualized and effective. Life science companies benefit from Mango Sciences' patient benefits program, which helps them tap into emerging market opportunities and expand the reach of precision medicine—an approach that tailors medical treatment to the individual characteristics of each patient.
Financial institutions also play a crucial role in Mango Sciences' ecosystem. By partnering with Mango, these institutions can generate more business and grow their revenue while positively impacting the entire healthcare value chain. This symbiotic relationship ensures that financial institutions contribute to making healthcare more accessible and affordable.
Mango Sciences operates primarily in the healthcare market, with a strong emphasis on emerging markets where access to precision medicine is often limited. The company's business model revolves around creating value for its clients through innovative healthcare solutions that are both accessible and affordable. Revenue is generated through partnerships, service agreements, and the implementation of their patient benefits programs.
In summary, Mango Sciences is committed to revolutionizing healthcare by making high-quality, individualized patient care accessible and affordable. Their holistic approach benefits healthcare providers, life science companies, and financial institutions alike, ensuring a positive impact across the entire healthcare ecosystem.
Keywords: healthcare, patient welfare, data-driven insights, precision medicine, accessibility, affordability, emerging markets, life science, financial institutions, innovative solutions.